Home › Funds › Geode Capital Management › PCVX
Geode Capital Management position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)3.46M sh
Reported value held$201.13M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 630.57K | $16.00M | New |
| Q4 2021 | 655.72K | $15.60M | Add |
| Q1 2022 | 721.96K | $17.43M | Add |
| Q2 2022 | 779.70K | $16.97M | Add |
| Q3 2022 | 894.79K | $21.47M | Add |
| Q4 2022 | 1.25M | $60.01K | Add |
| Q1 2023 | 1.33M | $49.82M | Add |
| Q2 2023 | 1.69M | $84.16M | Add |
| Q3 2023 | 1.88M | $95.60M | Add |
| Q4 2023 | 1.97M | $123.95M | Add |
| Q1 2024 | 2.29M | $156.27M | Add |
| Q2 2024 | 2.44M | $184.41M | Add |
| Q3 2024 | 2.70M | $308.67M | Add |
| Q4 2024 | 2.80M | $229.49M | Add |
| Q1 2025 | 2.87M | $108.36M | Add |
| Q2 2025 | 3.01M | $97.90M | Add |
| Q3 2025 | 2.88M | $103.90M | Reduce |
| Q4 2025 | 2.87M | $132.27M | Reduce |
| Q1 2026 | 3.20M | $186.06M | Add |
| Q2 2026 | 3.46M | $201.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026